Drug lookup
Drug reference

Alendronate

Bisphosphonate · Anti-osteoporotic

Also known as Alendronic acid, Alendronate sodium

BisphosphonateAnti-osteoporotic
CDSCO approved
EXCRETION
not curated
INTERACTIONS
none in our sources
PREGNANCY
Avoid.
FDA category + note

Mechanism

Alendronate, an aminobisphosphonate, primarily functions by directly inhibiting osteoclast-mediated bone resorption. It binds to hydroxyapatite in bone and is internalized by osteoclasts, leading to the suppression of their activity. This action reduces bone turnover, increases bone mineral density, and consequently lowers the risk of osteoporotic fractures.

Indications

Treatment of postmenopausal osteoporosisTreatment of osteoporosis in menPrevention and treatment of corticosteroid-induced osteoporosis in postmenopausal women not receiving hormone replacement therapyPaget diseasetreatment and prevention of osteoporosisglucocorticoid-associated osteoporosisPrevention of osteoporosis (women and men)Treatment of osteoporosis (women and men)Paget’s disease

Dosing

Adult
For postmenopausal osteoporosis: 10 mg daily by mouth, or 70 mg once weekly by mouth. For osteoporosis in men: 10 mg daily by mouth. For prevention and treatment of corticosteroid-induced osteoporosis in postmenopausal women not receiving hormone replacement therapy: 10 mg daily by mouth.
Renal adjustment
Avoid if eGFR less than 35 mL/minute/1.73 m2.
Geriatric
Potentially inappropriate (STOPP criteria) in patients with a current or recent history of upper gastrointestinal disease or bleeding (risk of relapse/exacerbation of oesophagitis, oesophageal ulcer, or oesophageal stricture).

Pharmacokinetics

Half-life
10.5 years (terminal elimination t½ in bone)
Bioavailability
<1%
Protein binding
78%
Excretion
44.9 ± 9.3%

Contraindications

  • Abnormalities of oesophagus
  • Hypocalcaemia
  • Other factors which delay oesophageal emptying (e.g., stricture or achalasia)
  • abnormalities that delay esophageal emptying
  • Gastroesophageal reflux
  • Peptic ulcer
  • Renal impairment

Side effects

Common
AlopeciaAnaemiaArthralgiaAstheniaConstipationDiarrhoeaDizzinessDysphagiaElectrolyte imbalanceEye inflammationFeverGastritisGastrointestinal discomfortGastrointestinal disordersHeadacheInfluenza-like illnessJoint swellingMalaiseMyalgiaNauseaOesophageal ulcerOesophagitisPainPeripheral oedemaRenal impairmentSkin reactionsTaste alteredVertigoVomitingheartburnesophageal irritationesophagitisabdominal paindiarrheaGastric irritationGastric erosionRetrosternal painFlatulenceBodyacheInitial fall in serum Ca2+ level
Serious
  • Anaphylactic reaction
  • Angioedema
  • Atypical femur fracture
  • Bronchospasm
  • Femoral stress fracture
  • Haemorrhage
  • Oesophageal stenosis
  • Osteonecrosis
  • Oropharyngeal ulceration
  • Photosensitivity reaction
  • Severe cutaneous adverse reactions (SCARs)
  • Severe oesophageal reactions (oesophagitis, oesophageal ulcers, oesophageal stricture, oesophageal erosions)
  • Stevens-Johnson syndrome
  • osteonecrosis of the jaw
  • fractures of the femoral shaft (most commonly associated)
  • esophageal ulcers
  • esophageal erosions

Pregnancy & lactation

Pregnancy

Avoid.

Lactation

Manufacturer advises avoid; no information available.

Drug interactions

Aceclofenac + Paracetamol
Moderate
Textbook

NSAIDs accentuate gastric irritation caused by alendronate.

Not explicitly stated, but implies caution or avoidance of co-administration if gastric irritation is a concern.

Source: KDT 7e · p345

Aceclofenac
Moderate
Textbook

NSAIDs accentuate gastric irritation caused by alendronate.

Not explicitly stated, but implies caution or avoidance of co-administration if gastric irritation is a concern.

Source: KDT 7e · p345

Antacids
Moderate
Textbook

Decreased absorption and efficacy of the bisphosphonate.

Oral bisphosphonates should be administered with a full glass of water following an overnight fast and at least 30 min before breakfast to avoid interaction with divalent cations.

Source: G&G 14e · p1060

Aspirin
Moderate
Textbook

NSAIDs accentuate gastric irritation caused by alendronate.

Not explicitly stated, but implies caution or avoidance of co-administration if gastric irritation is a concern.

Source: KDT 7e · p345

Bromfenac
Moderate
Textbook

NSAIDs accentuate gastric irritation caused by alendronate.

Not explicitly stated, but implies caution or avoidance of co-administration if gastric irritation is a concern.

Source: KDT 7e · p345

Capsaicin
Moderate
Textbook

NSAIDs accentuate gastric irritation caused by alendronate.

Not explicitly stated, but implies caution or avoidance of co-administration if gastric irritation is a concern.

Source: KDT 7e · p345

Choline Salicylate
Moderate
Textbook

NSAIDs accentuate gastric irritation caused by alendronate.

Not explicitly stated, but implies caution or avoidance of co-administration if gastric irritation is a concern.

Source: KDT 7e · p345

Coffee
Moderate
Textbook

Reduced alendronate absorption, potentially leading to reduced efficacy.

Alendronate must be taken on an empty stomach in the morning with a full glass of plain water, and the patient instructed not to lie down or take food for at least 30 min.

Source: KDT 7e · p345

Diclofenac
Moderate
Textbook

NSAIDs accentuate gastric irritation caused by alendronate.

Not explicitly stated, but implies caution or avoidance of co-administration if gastric irritation is a concern.

Source: KDT 7e · p345

Diclofenac + Paracetamol
Moderate
Textbook

NSAIDs accentuate gastric irritation caused by alendronate.

Not explicitly stated, but implies caution or avoidance of co-administration if gastric irritation is a concern.

Source: KDT 7e · p345

Etodolac
Moderate
Textbook

NSAIDs accentuate gastric irritation caused by alendronate.

Not explicitly stated, but implies caution or avoidance of co-administration if gastric irritation is a concern.

Source: KDT 7e · p345

Etoricoxib
Moderate
Textbook

NSAIDs accentuate gastric irritation caused by alendronate.

Not explicitly stated, but implies caution or avoidance of co-administration if gastric irritation is a concern.

Source: KDT 7e · p345

Related guidelines

Other Bisphosphonate drugs

Ask House about Alendronate

Continue into a citation-backed clinical answer with the drug context already attached.

Sources: KD Tripathi 7e, Goodman & Gilman 14e, Katzung, BNF·Verified: 2026-05-10 · House clinical team